1 reply to this topic

[onz]

Our next guest on the Longecity podcast is Kelsey Moody, CEO at Ichor Therapeutics.

 

It's been a few years since our last interview with Kelsey, Longecity have been helping to fund both research and interns at Ichor Therapeutics, a company that works to develop and commercialize research and clinical products in the field of regenerative medicine. Much of their focus has been on LysoSENS (clearing waste accumulation out of cells), cancer research, and C60 olive oil analysis. 

 

Let us know if you have any questions in the comments below, the interview is scheduled for Monday the 7th December.

 

Ichor pipeline

LysoSENS

Ichor Therapeutics website

[Mind]

The podcast is now available. This is a good one if you want to know the real nitty-gritty of how rejuvenation companies work. The headlines and PR blurbs might give the impression that things are always going smoothly in life extension research. The real situation is that it is just as hard to discover and market rejuvenation therapeutics as any other product.

 

Edited by Mind, 19 December 2020 - 01:58 PM.